X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-17 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale+OE | $156.45 | -116 | 11,316 | -1% | -$18,148 | |||||
2026-08-14 | CSTL | Castle Biosciences Inc | Stokes Frank | CFO | S - Sale | $29.77 | -24,908 | 35,177 | -41% | -$741,511 | ||||||
| D | 2026-08-14 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $30.02 | -7,232 | 209,247 | -3% | -$217,105 | |||||
2026-08-14 | ACON | Aclarion, Inc. | Gould Gregory A | CFO | P - Purchase | $2.45 | +10,000 | 60,000 | +20% | +$24,500 | ||||||
2026-08-17 | LH | Labcorp Holdings Inc. | Anderson Kerrii B | Dir | S - Sale | $318.02 | -3,000 | 6,851 | -30% | -$954,060 | ||||||
2026-08-13 | MDXH | Mdxhealth Sa | Mvm Partners, LLC | Dir | P - Purchase | $0.45 | +2,202,643 | 6,903,100 | +47% | +$1,000,000 | ||||||
2026-08-13 | ACON | Aclarion, Inc. | Bond Ryan | Dir | P - Purchase | $2.37 | +21,122 | 76,122 | +38% | +$50,059 | ||||||
2026-08-13 | ACON | Aclarion, Inc. | Wesemann William | Dir | P - Purchase | $2.34 | +2,150 | 23,713 | +10% | +$5,031 | ||||||
2026-08-13 | ACON | Aclarion, Inc. | Neal David K | Dir | P - Purchase | $2.40 | +7,500 | 30,002 | +33% | +$18,000 | ||||||
2026-08-13 | ACON | Aclarion, Inc. | Ness Brent | CEO | P - Purchase | $2.31 | +5,234 | 111,534 | +5% | +$12,091 | ||||||
2026-08-10 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $325.32 | -6,000 | 266,528 | -2% | -$1,951,942 | ||||||
| D | 2026-08-12 | GH | Guardant Health, Inc. | Monroe Terilyn J. | Chief People Officer | S - Sale+OE | $165.12 | -46,300 | 22,979 | -67% | -$7,645,218 | |||||
2026-08-12 | BDSX | Biodesix Inc | Schuler Jack W | Emeritus Director, 10% | P - Purchase | $24.47 | +15,000 | 2,355,810 | +1% | +$366,992 | ||||||
2026-08-10 | BLLN | Billiontoone, Inc. | Ten Bosch John Roderick | SVP of Laboratory Operations | S - Sale | $92.86 | -1,417 | 27,884 | -5% | -$131,583 | ||||||
| D | 2026-08-10 | BLLN | Billiontoone, Inc. | Tsao David | CTO | S - Sale+OE | $92.86 | -10,000 | 1,000 | -91% | -$928,600 | |||||
| M | 2026-08-10 | BDSX | Biodesix Inc | Schuler Jack W | Emeritus Director, 10% | P - Purchase | $24.13 | +27,600 | 2,340,810 | +1% | +$665,940 | |||||
2026-08-11 | LH | Labcorp Holdings Inc. | Schechter Adam H | Pres, CEO | S - Sale | $320.37 | -4,669 | 102,565 | -4% | -$1,495,808 | ||||||
| D | 2026-08-10 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | S - Sale+OE | $169.58 | -63,605 | 65,374 | -49% | -$10,786,111 | |||||
2026-08-07 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $320.90 | -2,000 | 2,277,394 | 0% | -$641,800 | ||||||
2026-08-07 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $315.66 | -9,150 | 272,528 | -3% | -$2,888,325 | ||||||
2026-08-06 | FTRE | Fortrea Holdings Inc. | Thakral Anshul | CEO | S - Sale | $18.12 | -111,857 | 204,940 | -35% | -$2,026,284 | ||||||
| D | 2026-08-05 | BLLN | Billiontoone, Inc. | Atay Oguzhan | COB, CEO | S - Sale+OE | $150.03 | -15,539 | 0 | -100% | -$2,331,352 | |||||
| D | 2026-08-05 | GH | Guardant Health, Inc. | Hidalgo Medina Manuel | Dir | S - Sale+OE | $164.24 | -1,700 | 4,556 | -27% | -$279,202 | |||||
| D | 2026-08-05 | FTRE | Fortrea Holdings Inc. | Thakral Anshul | CEO | S - Sale+OE | $19.16 | -99,869 | 316,797 | -24% | -$1,913,111 | |||||
2025-11-24 | CSTL | Castle Biosciences Inc | Juvenal Tobin W | Chief Commercial Officer | S - Sale | $38.39 | -1,301 | 77,694 | -2% | -$49,945 | ||||||
| DM | 2026-08-04 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $31.07 | -39,016 | 215,379 | -15% | -$1,212,230 | |||||
2026-08-05 | CDNA | Caredx, Inc. | Bickerstaff George | Dir | S - Sale | $46.29 | -20,000 | 134,061 | -13% | -$925,700 | ||||||
2026-08-04 | CDNA | Caredx, Inc. | Cournoyer Christine | Dir | S - Sale | $46.94 | -16,000 | 42,943 | -27% | -$750,973 | ||||||
2026-08-05 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $46.26 | -2,688 | 106,075 | -2% | -$124,349 | ||||||
2026-08-04 | CDNA | Caredx, Inc. | Goldberg Michael | Dir | S - Sale | $47.06 | -44,700 | 152,783 | -23% | -$2,103,497 | ||||||
2026-08-04 | LH | Labcorp Holdings Inc. | Summy Amy B. | EVP, CMO | S - Sale | $306.74 | -924 | 6,956 | -12% | -$283,428 | ||||||
| M | 2026-08-03 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $271.74 | -795 | 51,637 | -2% | -$216,030 | |||||
2026-08-03 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $266.40 | -3,076 | 99,897 | -3% | -$819,431 | ||||||
2026-08-03 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $267.99 | -295 | 183,774 | 0% | -$79,057 | ||||||
2026-08-03 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $265.58 | -3,410 | 129,019 | -3% | -$905,627 | ||||||
2026-08-03 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $267.99 | -334 | 170,073 | 0% | -$89,508 | ||||||
2026-08-03 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $267.99 | -731 | 2,279,394 | 0% | -$195,900 | ||||||
2026-08-03 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $267.99 | -109 | 281,678 | 0% | -$29,211 | ||||||
| D | 2026-08-03 | BLLN | Billiontoone, Inc. | Atay Oguzhan | COB, CEO | S - Sale+OE | $137.07 | -45,000 | 162,500 | -22% | -$6,167,960 | |||||
| D | 2026-08-04 | GH | Guardant Health, Inc. | Clark Ian T | Dir | S - Sale+OE | $158.92 | -14,180 | 2,975 | -83% | -$2,253,451 | |||||
2026-08-03 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $29.77 | -8,586 | 110,539 | -7% | -$255,622 | ||||||
2026-08-03 | FTRE | Fortrea Holdings Inc. | Sanders Machelle | Dir | S - Sale | $18.01 | -9,700 | 36,399 | -21% | -$174,697 | ||||||
| D | 2026-08-03 | LH | Labcorp Holdings Inc. | Wilkinson Peter J | SVP, Chief Accounting Officer | S - Sale+OE | $309.23 | -1,420 | 1,770 | -45% | -$439,107 | |||||
| M | 2026-07-31 | CSTL | Castle Biosciences Inc | Juvenal Tobin W | Chief Commercial Officer | S - Sale | $29.21 | -19,040 | 78,995 | -19% | -$556,175 | |||||
| DM | 2026-07-31 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $30.28 | -28,646 | 231,493 | -11% | -$867,451 | |||||
2026-07-31 | BLLN | Billiontoone, Inc. | Sakakibara Shan Riku | Chief Product Officer | S - Sale | $140.21 | -4,000 | 200,000 | -2% | -$560,840 | ||||||
| M | 2026-07-27 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $257.93 | -479 | 281,787 | 0% | -$123,549 | |||||
2026-07-27 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $260.49 | -1,718 | 2,280,125 | 0% | -$447,523 | ||||||
| M | 2026-07-27 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $257.08 | -1,887 | 170,407 | -1% | -$485,106 | |||||
| M | 2026-07-27 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $257.00 | -2,214 | 132,429 | -2% | -$568,997 | |||||
| M | 2026-07-27 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $257.00 | -1,713 | 184,069 | -1% | -$440,243 | |||||
| M | 2026-07-27 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $256.51 | -5,770 | 102,973 | -5% | -$1,480,047 | |||||
| M | 2026-07-27 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $253.29 | -5,064 | 52,432 | -9% | -$1,282,634 | |||||
2026-07-28 | DGX | Quest Diagnostics Inc | Delaney Mark E | SVP, Chief Commercial Officer | S - Sale | $235.18 | -1,600 | 10,335 | -13% | -$376,288 | ||||||
| D | 2026-07-27 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $24.16 | -9,836 | 242,995 | -4% | -$237,682 | |||||
2026-07-16 | BLLN | Billiontoone, Inc. | Johnson Nancy Joann | See Remarks | S - Sale | $128.29 | -14,199 | 6,900 | -67% | -$1,821,628 | ||||||
2026-07-15 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $273.88 | -1,500 | 282,266 | -1% | -$410,825 | ||||||
2026-07-15 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $274.82 | -135 | 4,663 | -3% | -$37,101 | ||||||
| D | 2026-07-16 | CDNA | Caredx, Inc. | Hanna John Walter Jr | Pres, CEO | S - Sale+OE | $37.79 | -118,000 | 653,448 | -15% | -$4,458,637 | |||||
| D | 2026-07-16 | CDNA | Caredx, Inc. | Valantine Hannah | Dir | S - Sale+OE | $36.15 | -28,779 | 36,686 | -44% | -$1,040,243 | |||||
2026-07-14 | CELC | Celcuity Inc. | Baker Bros. Advisors LP | Former 10% Owner | S - Sale | $102.50 | -3,100,000 | 4,372,852 | -41% | -$317,750,000 | ||||||
| D | 2026-07-16 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale+OE | $163.29 | -116 | 11,182 | -1% | -$18,942 | |||||
| D | 2026-07-14 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $22.92 | -4,172 | 246,617 | -2% | -$95,622 | |||||
| D | 2026-07-15 | PSNL | Personalis, Inc. | Chen Richard | Pres, CMO | S - Sale+OE | $15.15 | -100,000 | 173,880 | -37% | -$1,515,000 | |||||
2026-07-13 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $265.68 | -3,150 | 283,766 | -1% | -$836,898 | ||||||
2026-07-13 | BLLN | Billiontoone, Inc. | Ten Bosch John Roderick | SVP of Laboratory Operations | S - Sale | $125.46 | -4,251 | 29,301 | -13% | -$533,330 | ||||||
| D | 2026-07-13 | BLLN | Billiontoone, Inc. | Tsao David | CTO | S - Sale+OE | $124.89 | -20,000 | 1,000 | -95% | -$2,497,698 | |||||
| D | 2026-07-09 | BLLN | Billiontoone, Inc. | Atay Oguzhan | COB, CEO | S - Sale+OE | $126.10 | -12,500 | 0 | -100% | -$1,576,276 | |||||
| D | 2026-07-09 | BLLN | Billiontoone, Inc. | Sakakibara Shan Riku | Chief Product Officer | S - Sale+OE | $125.00 | -8,000 | 204,000 | -4% | -$1,000,000 | |||||
2026-05-15 | CAI | Caris Life Sciences, Inc. | Halbert Jon | Dir | P - Purchase | $14.56 | +68,000 | 1,461,106 | +5% | +$990,080 | ||||||
| D | 2026-07-09 | PSNL | Personalis, Inc. | Hall Christopher M | CEO | S - Sale+OE | $15.08 | -100,000 | 235,986 | -30% | -$1,508,000 | |||||
2026-07-06 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $280.00 | -1,000 | 2,281,843 | 0% | -$280,000 | ||||||
| D | 2026-07-06 | BLLN | Billiontoone, Inc. | Atay Oguzhan | COB, CEO | S - Sale+OE | $122.05 | -38,750 | 175,000 | -18% | -$4,729,379 | |||||
2026-07-01 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $272.29 | -16,800 | 172,294 | -9% | -$4,574,431 | ||||||
2026-07-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $272.90 | -3,000 | 134,643 | -2% | -$818,711 | ||||||
2026-07-01 | BLLN | Billiontoone, Inc. | Johnson Nancy Joann | See Remarks | S - Sale | $124.91 | -801 | 21,099 | -4% | -$100,056 | ||||||
| D | 2026-07-01 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $24.29 | -9,836 | 250,239 | -4% | -$238,916 | |||||
2026-07-01 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $24.42 | -8,586 | 119,125 | -7% | -$209,650 | ||||||
| D | 2026-07-02 | LH | Labcorp Holdings Inc. | Kyle Kathryn W | EVP, GC | S - Sale+OE | $286.19 | -92 | 3,904 | -2% | -$26,329 | |||||
| D | 2026-07-02 | LH | Labcorp Holdings Inc. | Vaughn Bryan T | EVP, Pres, Diagnostics | S - Sale+OE | $286.19 | -234 | 6,746 | -3% | -$66,968 | |||||
| M | 2026-06-11 | BNR | Burning Rock Biotech Ltd | Han Yusheng | Dir | P - Purchase | $8.45 | +731,410 | 18,404,086 | +4% | +$6,182,172 | |||||
2026-06-29 | BLLN | Billiontoone, Inc. | Ten Bosch John Roderick | SVP of Laboratory Operations | S - Sale | $120.00 | -1,416 | 33,552 | -4% | -$169,920 | ||||||
| M | 2026-06-10 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | S - Sale | $130.97 | -1,200 | 40,814 | -3% | -$157,164 | |||||
2026-06-15 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | P - Purchase | $130.76 | +600 | 40,814 | +1% | +$78,456 | ||||||
| DM | 2026-06-26 | CDNA | Caredx, Inc. | Hanna John Walter Jr | Pres, CEO | S - Sale+OE | $29.24 | -40,000 | 661,959 | -6% | -$1,169,736 | |||||
| DM | 2026-06-26 | GH | Guardant Health, Inc. | Talasaz Amirali | Co-CEO | S - Sale+OE | $151.20 | -260,000 | 1,881,336 | -12% | -$39,312,654 | |||||
| D | 2026-06-29 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale+OE | $14.00 | -4,982 | 198,833 | -2% | -$69,748 | |||||
2026-06-24 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $251.65 | -33,600 | 189,094 | -15% | -$8,455,355 | ||||||
2026-06-24 | NTRA | Natera, Inc. | Rosenman Herm | Dir | S - Sale | $250.00 | -16,530 | 4,250 | -80% | -$4,132,500 | ||||||
| D | 2026-06-26 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale+OE | $13.18 | -51,251 | 198,833 | -20% | -$675,488 | |||||
| D | 2026-06-26 | PSNL | Personalis, Inc. | Hall Christopher M | CEO | S - Sale+OE | $13.15 | -100,000 | 235,986 | -30% | -$1,315,000 | |||||
| D | 2026-06-24 | BLLN | Billiontoone, Inc. | Sakakibara Shan Riku | Chief Product Officer | S - Sale+OE | $110.00 | -8,000 | 208,000 | -4% | -$880,000 | |||||
2026-06-22 | AMS | American Shared Hospital Services | Stachowiak Raymond C | Exec COB, 10% | P - Purchase | $2.28 | +586,468 | 2,280,205 | +35% | +$1,337,147 | ||||||
2026-06-22 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $131.16 | -1,951 | 11,048 | -15% | -$255,893 | ||||||
2026-06-22 | GH | Guardant Health, Inc. | Potter Myrtle S | Dir | S - Sale | $131.16 | -1,556 | 20,971 | -7% | -$204,085 | ||||||
2026-06-17 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $219.87 | -1,500 | 286,916 | -1% | -$329,810 | ||||||
2026-06-18 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale | $52.89 | -3,729 | 15,097 | -20% | -$197,234 | ||||||
2026-06-18 | RDNT | Radnet, Inc. | Swartz David L | Dir | S - Sale | $53.89 | -2,699 | 214,032 | -1% | -$145,449 | ||||||
2026-06-16 | RDNT | Radnet, Inc. | Wesdorp Cornelis | Pres, CEO, Digital Health | S - Sale | $58.11 | -4,750 | 69,075 | -6% | -$276,023 | ||||||
2026-06-16 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $20.71 | -8,587 | 127,711 | -6% | -$177,837 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |